标题
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
作者
关键词
-
出版物
Frontiers in Immunology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-12-20
DOI
10.3389/fimmu.2016.00606
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dysregulation of regulatory CD56 bright NK cells/T cells interactions in multiple sclerosis
- (2016) Alice Laroni et al. JOURNAL OF AUTOIMMUNITY
- Relationship ofNKG2CCopy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets
- (2016) Aura Muntasell et al. JOURNAL OF IMMUNOLOGY
- Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation
- (2016) Qiang Liu et al. NATURE NEUROSCIENCE
- Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation
- (2016) Catharina C. Gross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
- (2016) Obinna Chijioke et al. Frontiers in Immunology
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis
- (2015) E. Rodríguez-Martín et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
- (2015) Heinrich Schlums et al. IMMUNITY
- Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
- (2015) Tobias Ruck et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
- (2015) Aleksanteri Aspelund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD56brightCD16−NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+T Cell Proliferation
- (2015) Fabio Morandi et al. JOURNAL OF IMMUNOLOGY
- Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis
- (2015) Jose E Martínez-Rodríguez et al. Multiple Sclerosis Journal
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade
- (2015) M. Mehling et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Cytomegalovirus: a culprit or protector in multiple sclerosis?
- (2015) Marjan Vanheusden et al. TRENDS IN MOLECULAR MEDICINE
- Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis
- (2015) Jose E Martínez-Rodríguez et al. Multiple Sclerosis Journal
- Optimizing therapy early in multiple sclerosis: An evidence-based view
- (2015) Tjalf Ziemssen et al. Multiple Sclerosis and Related Disorders
- Role for early-differentiated natural killer cells in infectious mononucleosis
- (2014) T. Azzi et al. BLOOD
- Regulatory T cells in autoimmune neuroinflammation
- (2014) Markus Kleinewietfeld et al. IMMUNOLOGICAL REVIEWS
- Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases
- (2014) S. Han et al. JOURNAL OF IMMUNOLOGY
- Proliferation Conditions Promote Intrinsic Changes in NK Cells for an IL-10 Response
- (2014) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells
- (2014) Guido Ferlazzo et al. Frontiers in Immunology
- Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation
- (2013) Fabio Morandi et al. Journal of Neuroimmune Pharmacology
- Epstein-Barr Virus Coinfection in Children Boosts Cytomegalovirus-Induced Differentiation of Natural Killer Cells
- (2013) S. Saghafian-Hedengren et al. JOURNAL OF VIROLOGY
- HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients
- (2013) Kim Pannemans et al. Multiple Sclerosis Journal
- Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
- (2013) Heinz Wiendl et al. Nature Reviews Neurology
- The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
- (2013) Coralie Chanvillard et al. Frontiers in Immunology
- Increased HLA-E expression in white matter lesions in multiple sclerosis
- (2012) Pascal F. Durrenberger et al. IMMUNOLOGY
- Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
- (2012) Isabell Hamann et al. JOURNAL OF NEUROIMMUNOLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
- (2012) Natasja Nielsen et al. PLoS One
- Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
- (2012) Barbara Morandi et al. PLoS One
- Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis
- (2012) J. S. A. Perry et al. Science Translational Medicine
- Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients
- (2011) T. A. Johnson et al. JOURNAL OF IMMUNOLOGY
- Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
- (2011) W. Jiang et al. JOURNAL OF IMMUNOLOGY
- Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
- (2011) Mario Skarica et al. JOURNAL OF NEUROIMMUNOLOGY
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Intrathecal effects of daclizumab treatment of multiple sclerosis
- (2011) B. Bielekova et al. NEUROLOGY
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
- (2011) Alice Laroni et al. PLoS One
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
- (2010) Norman Putzki et al. EUROPEAN NEUROLOGY
- Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph
- (2010) Erika Montalto et al. IMMUNOLOGY LETTERS
- Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology
- (2010) Junwei Hao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
- (2010) J. F. Martin et al. JOURNAL OF IMMUNOLOGY
- Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2
- (2010) J. W. Leavenworth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
- (2009) Bibiana Bielekova et al. ARCHIVES OF NEUROLOGY
- Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction
- (2009) E. Marcenaro et al. BLOOD
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
- (2009) Glinda S. Cooper et al. JOURNAL OF AUTOIMMUNITY
- T-bet–dependent S1P5expression in NK cells promotes egress from lymph nodes and bone marrow
- (2009) Craig N. Jenne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection
- (2009) Seung-Hwan Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of the innate immune system in the pathogenesis of multiple sclerosis
- (2009) Roopali Gandhi et al. JOURNAL OF NEUROIMMUNOLOGY
- Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
- (2008) Philip L. De Jager et al. BRAIN
- Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?
- (2008) J. D. Lunemann et al. BRAIN
- CD56brightnatural killer (NK) cells: an important NK cell subset
- (2008) Aurélie Poli et al. IMMUNOLOGY
- Role of natural killer cells in the pathogenesis and progression of multiple sclerosis
- (2007) Barbara Morandi et al. PHARMACOLOGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now